Literature DB >> 19374006

Update on the podocyte.

Peter W Mathieson1.   

Abstract

PURPOSE OF REVIEW: The podocyte is a key cell in the selective filtering action of the glomerular capillary wall. Podocyte injury is of pathogenetic and prognostic significance in human glomerular disease; podocyte repair and regeneration are important therapeutic targets. This article will review recent advances in understanding the complex biology, structure and function of the podocyte and the related clinical implications. RECENT
FINDINGS: Recent studies of podocytes in vivo and in vitro are described, highlighting clinically relevant observations and those that help us to understand the ways in which we may harness nature's own mechanisms to repair and/or renew these specialized glomerular cells.
SUMMARY: Drugs that have beneficial effects on podocytes can improve our ability to treat important renal diseases, including diabetic nephropathy. Currently available agents can be harnessed in this way and the rapid progress in the study of podocytes is highlighting new therapeutic targets that can bring even more specificity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19374006     DOI: 10.1097/mnh.0b013e328326f3ca

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  15 in total

1.  Differential microRNA expression in the serum of patients with nephrotic syndrome and clinical correlation analysis.

Authors:  Jian Teng; Fang Sun; Peng-Fei Yu; Ji-Xia Li; Dong Yuan; Jing Chang; Shu-Hua Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP).

Authors:  John R Sedor; Sethu M Madhavan; Jane H Kim; Martha Konieczkowski
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

3.  Using stereologic techniques for podocyte counting in the mouse: shifting the paradigm.

Authors:  Susanne B Nicholas; John M Basgen; Satyesh Sinha
Journal:  Am J Nephrol       Date:  2011-06-10       Impact factor: 3.754

4.  Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.

Authors:  Zhen Wang; Hui Bao; Yan Ge; Shougang Zhuang; Ai Peng; Rujun Gong
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

5.  Shear stress induces cell apoptosis via a c-Src-phospholipase D-mTOR signaling pathway in cultured podocytes.

Authors:  Chunfa Huang; Leslie A Bruggeman; Lindsey M Hydo; R Tyler Miller
Journal:  Exp Cell Res       Date:  2012-03-26       Impact factor: 3.905

6.  Common variation in GPC5 is associated with acquired nephrotic syndrome.

Authors:  Koji Okamoto; Katsushi Tokunaga; Kent Doi; Toshiro Fujita; Hodaka Suzuki; Tetsuo Katoh; Tsuyoshi Watanabe; Nao Nishida; Akihiko Mabuchi; Atsushi Takahashi; Michiaki Kubo; Shiro Maeda; Yusuke Nakamura; Eisei Noiri
Journal:  Nat Genet       Date:  2011-03-27       Impact factor: 38.330

7.  Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathy.

Authors:  P Anil Kumar; Kateryna Kotlyarevska; Prapai Dejkhmaron; Gaddameedi R Reddy; Chunxia Lu; Mahaveer S Bhojani; Ram K Menon
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

Review 8.  The glomerulus--a view from the outside--the podocyte.

Authors:  Huifang Cheng; Raymond C Harris
Journal:  Int J Biochem Cell Biol       Date:  2010-06-11       Impact factor: 5.085

9.  The targeted podocyte.

Authors:  Agnes B Fogo
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

Review 10.  The podocyte as a target for therapies--new and old.

Authors:  Peter W Mathieson
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.